IATDMCT 2017

Presentation information

Print

Educational Lecture

[EL-13] EL-13: Exposure-response of erlotinib in patients with non-small cell lung cancer

Tue. Sep 26, 2017 3:15 PM - 4:05 PM Room Swan (1F)

Chair: Yasutsuna Sasaki, Japan

Sponsored by Chugai Pharmaceutical Co., Ltd.

[EL-13] Exposure-response analysis of erlotinib for individualized dosing based on TDM

Chiyo K. Imamura (Keio University School of Medicine, Japan)

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Password